Restrepo-Giraldo LM

Language: Spanish
References: 7
Page: 209-212
PDF size: 208.75 Kb.

Text Extraction

No abstract.

REFERENCES

1. Anderson RA, Nelson SM, Wallace WH. Measuring Anti-müllerian hormone for the assessment of ovarian reserve: when and for whom is it indicated? Maturitas 2012; 71: 28-33.

2. Broer SL, Eijkemans MJ, Scheffer GJ, van Rooij IA, de Vet A, Themmen AP, et al. Anti-müllerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab 2011; 96: 2532-2539.

3. Fanchin R, Taieb J, Lozano DH, Ducot B, Frydman R, Bouyer J. High reproducibility of serum Anti-müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 2005; 20: 923-927.

4. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010; 16: 113-130.

5. La Marca A, Nelson SM, Sighinolfi G, Manno M, Baraldi E, Roli L, et al. Anti-müllerian hormone- based prediction model for a live birth in assisted reproduction. Reprod Biomed Online 2011; 22: 341-349.

6. La Marca A, Stabile G, Artenisio AC, Volpe A. Serum Anti-müllerian hormone throughout the human menstrual cycle. Hum Reprod 2006; 21: 3103-3107.

7. Yates AP, Rustamov O, Roberts SA, Lim HY, Pemberton PW, Smith A, et al. Anti-müllerian hormone- tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF. Hum Reprod 2011; 26: 2353-2362.